Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

FDA Analysis of Screen Failures By Race in Clinical Trials of Acute Myeloid Leukemia

Dianne Pulte, MD, Guo Wei, Kelly J. Norsworthy, MD, Yutao Gong, PhD, Nicole J. Gormley, MD, Bindu Kanapuru, MD, Richard Pazdur, MD, Julie Schneider, Marc Theoret, MD, Angelo De Claro, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-136363

Published: 2020

Journal Articles

Population Level Survival for Patients with Multiple Myeloma By Insurance Type and Early Indications of Changes with Adoption of the Medicaid Expansion of the Affordable Care Act

Dianne Pulte, MD, Lina Jansen, PhD, Janick Weberpals, Hermann Brenner, MD MPH

Blood (2017) 130 (Supplement 1): 3438.

https://doi.org/10.1182/blood.V130.Suppl_1.3438.3438

Published: 2017

Journal Articles

Updated Population Based Survival Analysis in Patients with Chronic Myeloid Leukemia: Increased Survival but Continued Disparities for Older Patients

Dianne Pulte, MD, Lina Jansen, PhD, Janick Weberpals, Hermann Brenner, MD MPH

Blood (2017) 130 (Supplement 1): 2192.

https://doi.org/10.1182/blood.V130.Suppl_1.2192.2192

Published: 2017

Journal Articles

Most up-to-Date Long Term Survival Estimates for Common Hematologic Malignancies Using the Boomerang Method

Dianne Pulte, MD, Lina Jansen, PhD, Hermann Brenner, MD MPH

Blood (2016) 128 (22): 2409.

https://doi.org/10.1182/blood.V128.22.2409.2409

Published: 2016

Journal Articles

Population Level Survival for Patients with Rare Hematologic Malignancies in the United States in the Early 21 st Century

Dianne Pulte, MD, Janick Weberpals, Lina Jansen, PhD, Alexander Katalinic, PhD, Alice Nennecke, MD MPH, Bernd Holleczek, MD, Meike Ressing, MSc, Sabine Luttmann, PhD, Hermann Brenner, MD MPH

Blood (2016) 128 (22): 2416.

https://doi.org/10.1182/blood.V128.22.2416.2416

Published: 2016

Journal Articles

Survival of Patients with Rare Plasma Cell or Lymphoplasmacytoid Malignancies in Germany and the United States in the Early 21 st Century

Dianne Pulte, MD, Janick Weberpals, Lina Jansen, PhD, Alexander Katalinic, PhD, Alice Nennecke, MD MPH, Holleczek Bernd, MD, Ressing Meike, PhD, Luttmann Sabine, MD, Hermann Brenner, MD MPH

Blood (2016) 128 (22): 4767.

https://doi.org/10.1182/blood.V128.22.4767.4767

Published: 2016

Journal Articles

Characteristics of "Older Old" Patients with Sickle Cell Anemia Who Survived for More Than 80 Years

Dianne Pulte, MD, Gaye Riddick-Burden, MSN, Samir K. Ballas, MD

Blood (2015) 126 (23): 4599.

https://doi.org/10.1182/blood.V126.23.4599.4599

Published: 2015

Journal Articles

Changes in Survival of Older Patients with Hematologic Malignancies in the Early 21 st Century

Dianne Pulte, MD, Lina Jansen, PhD, Felipe Castro, PhD, Hermann Brenner, MD MPH

Blood (2015) 126 (23): 3288.

https://doi.org/10.1182/blood.V126.23.3288.3288

Published: 2015

Journal Articles

Changes in Survival in Acute Myeloblastic Leukemia by Racial and Ethnic Group: Greater Improvement for Non-Hispanic Whites and Increase in the Disparity for Minority Patients in the Early 21 st Century

Dianne Pulte, MD, Maria Theresa Redaniel, PhD, Hermann Brenner, MD, MPH, Lina Jansen, PhD, Mona Jeffreys, PhD

Blood (2011) 118 (21): 844.

https://doi.org/10.1182/blood.V118.21.844.844

Published: 2011

Journal Articles

Population Level Survival for Patients with Multiple Myeloma: Variation and Growing Disparity for Patients of Minority Race or Ethnicity

Dianne Pulte, MD, Maria Theresa Redaniel, PhD, Hermann Brenner, MD, MPH, Lina Jansen, PhD, Mona Jeffreys, PhD

Blood (2011) 118 (21): 3126.

https://doi.org/10.1182/blood.V118.21.3126.3126

Published: 2011

Journal Articles

Improvement In Survival of Patients with Multiple Myeloma: An Update of Population Based Survival Trends

Dianne Pulte, MD, Adam Gondos, Hermann Brenner

Blood (2010) 116 (21): 1510.

https://doi.org/10.1182/blood.V116.21.1510.1510

Published: 2010

Journal Articles

Survival of Patients with Chronic Myelocytic Leukemia:Comparisons of Estimates From Clinical Trial Settings and Population-Based Cancer Registrtation.

Dianne Pulte, MD, Adam Gondos, Teresa Redaniel, Hermann Brenner

Blood (2009) 114 (22): 899.

https://doi.org/10.1182/blood.V114.22.899.899

Published: 2009

Journal Articles

Expected Long-Term Survival of Older Patients Diagnosed with Non-Hodgkin Lymphoma in 2007-2011.

Dianne Pulte, MD, Adam Gondos, Hermann Brenner

Blood (2009) 114 (22): 4525.

https://doi.org/10.1182/blood.V114.22.4525.4525

Published: 2009

Journal Articles

Trends in Survival after Diagnosis with Hematologic Malignancy in Adolescence or Young Adulthood in the United States, 1981- 2005

Dianne Pulte, MD, Adam Gondos, Hermann Brenner

Blood (2008) 112 (11): 877.

https://doi.org/10.1182/blood.V112.11.877.877

Published: 2008

Journal Articles

Platelet Reactivity and CD39 Ectonucleotidase Activities in Cryptogenic Stroke

Aaron J. Marcus, MD, Marinus Johan Broekman, PhD, Joan HF Drosopoulos, PhD, Kim E. Olson, MD, Dianne Pulte, MD, Jorge R. Kizer

Blood (2008) 112 (11): 3817.

https://doi.org/10.1182/blood.V112.11.3817.3817

Published: 2008

Journal Articles

Expected Long-Term Survival of Patients Diagnosed with Multiple Myeloma in 2006–2010

Hermann Brenner, Adam Gondos, Dianne Pulte, MD

Blood (2008) 112 (11): 2368.

https://doi.org/10.1182/blood.V112.11.2368.2368

Published: 2008

Journal Articles

Nucleotidase Activity of CD39/NTPDase1 Is Dependent on Internal Proteolytic Cleavage Which Contributes to Lipid Raft Localization.

Kim E. Olson, MD, Marinus Johan Broekman, PhD, Ashley E. Olson, BS, Dianne Pulte, MD, Aaron J. Marcus, MD

Blood (2007) 110 (11): 3634.

https://doi.org/10.1182/blood.V110.11.3634.3634

Published: 2007

Journal Articles

Ongoing Strong Improvement in Survival after Diagnosis with Childhood Hematologic Malignancies.

Dianne Pulte, MD, Adam Gondos, PhD, Hermann Brenner, MD

Blood (2007) 110 (11): 3313.

https://doi.org/10.1182/blood.V110.11.3313.3313

Published: 2007

Journal Articles

Ongoing Strong Improvement in Treatment Outcomes for Patients Diagnosed with Non-Hodgkin Lymphoma from the 1990s to the Early 21st Century.

Dianne Pulte, MD, Adam Gondos, PhD, Hermann Brenner, MD

Blood (2007) 110 (11): 3314.

https://doi.org/10.1182/blood.V110.11.3314.3314

Published: 2007

Journal Articles

Major Improvements in Survival in Hematologic Malignancies in the Early 2000s.

Dianne Pulte, MD, Adam Gondos, PhD, Hermann Brenner, MD

Blood (2007) 110 (11): 632.

https://doi.org/10.1182/blood.V110.11.632.632

Published: 2007

NARROW

FDA Analysis of Screen Failures By Race in Clinical Trials of Acute Myeloid Leukemia

Population Level Survival for Patients with Multiple Myeloma By Insurance Type and Early Indications of Changes with Adoption of the Medicaid Expansion of the Affordable Care Act

Updated Population Based Survival Analysis in Patients with Chronic Myeloid Leukemia: Increased Survival but Continued Disparities for Older Patients

Most up-to-Date Long Term Survival Estimates for Common Hematologic Malignancies Using the Boomerang Method

Population Level Survival for Patients with Rare Hematologic Malignancies in the United States in the Early 21 st Century

Survival of Patients with Rare Plasma Cell or Lymphoplasmacytoid Malignancies in Germany and the United States in the Early 21 st Century

Characteristics of "Older Old" Patients with Sickle Cell Anemia Who Survived for More Than 80 Years

Changes in Survival of Older Patients with Hematologic Malignancies in the Early 21 st Century

Changes in Survival in Acute Myeloblastic Leukemia by Racial and Ethnic Group: Greater Improvement for Non-Hispanic Whites and Increase in the Disparity for Minority Patients in the Early 21 st Century

Population Level Survival for Patients with Multiple Myeloma: Variation and Growing Disparity for Patients of Minority Race or Ethnicity

Improvement In Survival of Patients with Multiple Myeloma: An Update of Population Based Survival Trends

Survival of Patients with Chronic Myelocytic Leukemia:Comparisons of Estimates From Clinical Trial Settings and Population-Based Cancer Registrtation.

Expected Long-Term Survival of Older Patients Diagnosed with Non-Hodgkin Lymphoma in 2007-2011.

Trends in Survival after Diagnosis with Hematologic Malignancy in Adolescence or Young Adulthood in the United States, 1981- 2005

Platelet Reactivity and CD39 Ectonucleotidase Activities in Cryptogenic Stroke

Expected Long-Term Survival of Patients Diagnosed with Multiple Myeloma in 2006–2010

Nucleotidase Activity of CD39/NTPDase1 Is Dependent on Internal Proteolytic Cleavage Which Contributes to Lipid Raft Localization.

Ongoing Strong Improvement in Survival after Diagnosis with Childhood Hematologic Malignancies.

Ongoing Strong Improvement in Treatment Outcomes for Patients Diagnosed with Non-Hodgkin Lymphoma from the 1990s to the Early 21st Century.

Major Improvements in Survival in Hematologic Malignancies in the Early 2000s.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only